Cargando…

Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice

Non-alcoholic fatty liver disease (NAFLD) leads to steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma. For sedentary patients, lifestyle interventions combining exercise and dietary changes are a cornerstone of treatment. However, the benefit of exercise alone when dietary changes have f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarino, Maria, Kumar, Pavitra, Felser, Andrea, Terracciano, Luigi M., Guixé-Muntet, Sergi, Humar, Bostjan, Foti, Michelangelo, Nuoffer, Jean-Marc, St-Pierre, Marie V., Dufour, Jean-François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352494/ https://www.ncbi.nlm.nih.gov/pubmed/32486073 http://dx.doi.org/10.3390/cancers12061407

Ejemplares similares

Anti‐tumoral effects of exercise on hepatocellular carcinoma growth
por: Saran, Uttara, et al.
Publicado: (2018)

Review article: vascular effects of PPARs in the context of NASH
por: Guixé‐Muntet, Sergi, et al.
Publicado: (2022)

Advances in therapeutic options for portal hypertension
por: Vilaseca, Marina, et al.
Publicado: (2018)

4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
por: Fernández‐Iglesias, Anabel, et al.
Publicado: (2018)

Regression of portal hypertension: underlying mechanisms and therapeutic strategies
por: Selicean, Sonia, et al.
Publicado: (2021)

Mechanobiology of portal hypertension
por: Felli, Eric, et al.
Publicado: (2023)

Nuclear deformation mediates liver cell mechanosensing in cirrhosis
por: Guixé-Muntet, Sergi, et al.
Publicado: (2020)

The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
por: Gibert-Ramos, Albert, et al.
Publicado: (2021)

Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
por: Dufour, Jean-François, et al.
Publicado: (2020)

Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis
por: Correia de Sousa, Marta, et al.
Publicado: (2021)

Ces3/TGH Deficiency Attenuates Steatohepatitis
por: Lian, Jihong, et al.
Publicado: (2016)

Effects of silica nanoparticle exposure on mitochondrial function during neuronal differentiation
por: Ducray, Angélique D., et al.
Publicado: (2017)

Live monitoring of cellular metabolism and mitochondrial respiration in 3D cell culture system using NMR spectroscopy
por: Hertig, Damian, et al.
Publicado: (2021)

Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis
por: Dongiovanni, Paola, et al.
Publicado: (2015)

Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis
por: Ninomiya, Masashi, et al.
Publicado: (2012)

Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
por: de Mesquita, Fernanda Cristina, et al.
Publicado: (2017)

Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte‐Mediated Paracrine Mechanism
por: Gracia‐Sancho, Jordi, et al.
Publicado: (2019)

A Metabolomic Analysis of Omega-3 Fatty Acid-Mediated Attenuation of Western Diet-Induced Nonalcoholic Steatohepatitis in LDLR (-/-) Mice
por: Depner, Christopher M., et al.
Publicado: (2013)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
por: Zhou, Lishan, et al.
Publicado: (2017)

Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
por: Li, Rui, et al.
Publicado: (2018)

Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
por: Lee, Jung Il, et al.
Publicado: (2019)

Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
por: Morishita, Asahiro, et al.
Publicado: (2022)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Fatty Acid Elongation in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Kessler, Sonja M., et al.
Publicado: (2014)

Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
por: Yoo, Wonbeak, et al.
Publicado: (2017)

Short-Term Fasting Attenuates Overall Steroid Hormone Biosynthesis in Healthy Young Women
por: Magyar, Benjamin P, et al.
Publicado: (2022)

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
por: Peiseler, Moritz, et al.
Publicado: (2021)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013)

A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis
por: Ai, Luoyan, et al.
Publicado: (2015)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
por: Liu, Yu, et al.
Publicado: (2021)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

Nicotinamide and NAFLD: Is There Nothing New Under the Sun?
por: Guarino, Maria, et al.
Publicado: (2019)

IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
por: Mas, Emmanuel, et al.
Publicado: (2009)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice
por: Nishikawa, Tomoki, et al.
Publicado: (2020)

Attenuation of Perfluorooctane Sulfonate-Induced Steatohepatitis by Grape Seed Proanthocyanidin Extract in Mice
por: Huang, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iq1aamd4hn5fl2grd9fpp8pbsh